Targeting HER2 in NSCLC
Podcast | English | 2021 | 39 Min
Image For Activity Cover
Credit
No Credit Offered
About 20 percent of breast cancer cases have a link to the protein HER2, but HER2's link to lung cancer is not as common, and effective therapies have eluded lung cancer researchers. To learn more about the state of HER2 research for lung cancer, listen to this episode of Lung Cancer Considered with host Dr. Stephen Liu and Dr. Bob T. Li, Medical Oncologist from Memorial Sloan Kettering.
Dr. Stephen Liu
Dr. Bob T. Li
Powered By